CLINICAL_TRIALS
trial_result
· 2017-11-17
Clinical Trial Update: Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients [Phase 4]
Summary
Phase 4 safety study update on continued enzalutamide treatment in prostate cancer patients; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED | Results posted: 2017-11-17